Tu Diep
Corporate Officer/Principal presso SKYE BIOSCIENCE, INC.
Patrimonio netto: 815 682 $ in data 30/06/2024
Provenienza dei contatti di primo grado di Tu Diep
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 11 | |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA.
1
| Private Company | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tu Diep tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer Founder Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Emerald Health Sciences, Inc.
 Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Sciences, Inc. develops cannabinoid pharmaceutical drugs. It targets botanicals including medical & recreational and nutraceutical segments. The company was founded on July 31 2007is headquartered in Victoria, Canada. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| ARCH THERAPEUTICS, INC. | Medical Distributors | Chairman Director/Board Member | |
Emerald Health Pharmaceuticals, Inc.
 Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| EMERALD HEALTH THERAPEUTICS | Agricultural Commodities/Milling | Chief Executive Officer Director/Board Member | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Chairman Chief Executive Officer | |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SENOMYX INC. | Food: Specialty/Candy | Chief Executive Officer | |
| FATE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Fellow Health, Inc.
 Fellow Health, Inc. Medical SpecialtiesHealth Technology Fellow Health, Inc. is a company that offers at-home fertility testing for men. Fellow Health is based in San Leandro, CA and was founded by Graham Gilkerson and William Matthews. The company's service allows men to test their sperm privately from home and receive a doctor-reviewed male fertility report with detailed semen analysis results. In addition to their at-home testing service, the company also helps clinicians streamline their workflows and improve patient experience. William Matthews has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Naviscan, Inc.
 Naviscan, Inc. Electronic Production EquipmentElectronic Technology Naviscan, Inc. develops, manufactures, and markets organ molecular imaging scanners. The company was founded by Irving Weinberg on January 31, 2006 and is headquartered in San Diego, CA. | Electronic Production Equipment | Chairman | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Chairman | |
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Investment Managers | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| University of California, Irvine | College/University | Masters Business Admin | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| 5AM Partners III LLC | Corporate Officer/Principal | ||
| 501 ACQU | Financial Conglomerates | Chief Executive Officer | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member | |
| 5AM Partners LLC | Corporate Officer/Principal | ||
| 5AM Partners II LLC | Corporate Officer/Principal | ||
| 5am Partners IV LLC | Corporate Officer/Principal | ||
| PEAR THERAPEUTICS, INC. | Medical Specialties | Director/Board Member | |
| 5AM Partners V LLC | Corporate Officer/Principal | ||
| 5AM Opportunities I GP LLC | Corporate Officer/Principal | ||
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Biotie Therapies AG
 Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding company that focuses on developing drugs for the treatment of psychiatry and neurology diseases. The company is based in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| VIVEVE MEDICAL, INC. | Medical Specialties | Director/Board Member | |
| Presidio Terrace | Director/Board Member | ||
| 5am Partners Vi LLC | Corporate Officer/Principal | ||
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Biotechnology | Corporate Officer/Principal | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member | |
Third Rock Ventures LP
 Third Rock Ventures LP Investment ManagersFinance Third Rock Ventures LP seeks investment opportunities in life science companies located in the United States. The fund targets companies operating in the fields of sciences primarily in biotechnology, biopharmaceutical and medical devices. It provides financing for early stage capital requirements with an initial investment size of up to $30 million. It also acts as a lead investor. | Investment Managers | Founder | |
| Oregon Health & Science University | College/University | Doctorate Degree | |
Onchilles Pharma, Inc.
 Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Onchilles Pharma, Inc. engages in the provision of biotechnology services. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| RAYZEBIO, INC. | Biotechnology | Founder | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder | |
| The University of North Carolina at Chapel Hill | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Canada | 4 |
| Irlanda | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 85 |
| Corporate Officer/Principal | 35 |
| President | 22 |
| Chief Executive Officer | 21 |
| Independent Dir/Board Member | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Andrew Schwab | 45 |
| Avtar Dhillon | 25 |
| Praveen Tyle | 23 |
| Paul Grayson | 21 |
| Punit Dhillon | 15 |
| Margaret Dalesandro | 13 |
| Keith Ward | 9 |
| Deborah Charych | 8 |
| Christopher G. Twitty | 5 |
| Kaitlyn Arsenault | 4 |
| Rhea Williams | 4 |
| Karam Takhar | 2 |
- Borsa valori
- Insiders
- Tu Diep
- Connessioni Società
